Triethylamine → HCID 69300815, compound
Reaction equation
Cl.[CH2:2]([O:4][C:5]1[CH:6]=[C:7]([CH:44]=[CH:45][CH:46]=1)[CH2:8][N:9]1[C:13]2=[N:14][CH:15]=[N:16][C:17]([N:18]3[CH2:23][CH2:22][N:21]([C:24](=[O:43])[C:25]4[CH:30]=[CH:29][C:28]([N:31]([C:37](=[O:42])[CH2:38][CH2:39][NH:40][CH3:41])[CH2:32][CH2:33][N:34]([CH3:36])[CH3:35])=[CH:27][CH:26]=4)[CH2:20][CH2:19]3)=[C:12]2[CH:11]=[N:10]1)[CH3:3].[Cl:47][C:48]([O:50][CH2:51][CH3:52])=[O:49].C(N(CC)CC)C>C(Cl)Cl.C(=O)([O-])O.[Na+]>[ClH:47].[CH2:2]([O:4][C:5]1[CH:6]=[C:7]([CH:44]=[CH:45][CH:46]=1)[CH2:8][N:9]1[C:13]2=[N:14][CH:15]=[N:16][C:17]([N:18]3[CH2:23][CH2:22][N:21]([C:24](=[O:43])[C:25]4[CH:26]=[CH:27][C:28]([N:31]([C:37](=[O:42])[CH2:38][CH2:39][N:40]([CH3:41])[C:48]([O:50][CH2:51][CH3:52])=[O:49])[CH2:32][CH2:33][N:34]([CH3:36])[CH3:35])=[CH:29][CH:30]=4)[CH2:20][CH2:19]3)=[C:12]2[CH:11]=[N:10]1)[CH3:3]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of the compound obtained in Example 725 (50 mg) in methylene chloride (3 mL) is added ethyl chloroformate (10 μL) and triethylamine (22 μL) and the mixture is stirred at room temperature overnight. The reaction mixture is diluted with a saturated sodium hydrogencarbonate solution and the mixture is extracted with chloroform. The organic layer is evaporated to remove solvent and the residue is purified by column chromatography on silica gel (solvent; chloroform/methanol=10:1), and the resultant product is treated in the same manner as described in Example 4 (3) to give 1-(3-ethoxybenzyl)-4-[4-[4-[N-[3-[N-methyl-N-(ethoxycarbonyl)amino]-propionyl)-N-[2-(dimethylamino)ethyl]amino]benzoyl]piperazin-1-yl]-1H-pyrazolo-[3,4-d]pyrimidine hydrochloride (17 mg, yield; 30%) as an amorphous powder. MS (APCI) m/z: 686 [M+H]+
Workup
- extractionthe mixture is extracted with chloroform
- customThe organic layer is evaporated
- customto remove solvent
- customthe residue is purified by column chromatography on silica gel (solvent; chloroform/methanol=10:1)
- additionthe resultant product is treated in the same manner
Sources & evidence
- ORD record
- ord-eff5e6d039a34194abcdacea37bfc732
- Source dataset
- uspto-grants-2008_06
- Patent number
- US07384952B2
Reaction notes
Loading…